Pharma Insider Sells 4,772 Shares as 2025 Revenue Hits $883M
A high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
This piece analyzes whether retirement funds should favor index or target date options, emphasizing long-term planning and goal alignment.
26,209 articlesA high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
Robinhood unveils a fresh round of layoffs, cutting about 290 jobs to streamline its structure, while reporting solid...
Jamie Dimon argues that insecurity is the real career killer for CEOs as they move from specialists to generalists. T...
State Street’s 2026 ETF Outlook pushes a shift to multi-coin crypto ETFs, but a standout XRP ticker shows the sector ...
Solana has landed Moody’s on-chain ratings, enabling open access to standardized credit analysis for tokenized assets...
A historic 93% one-day rally in a well-known automaker set a record for the largest single-day stock gain, prompting ...
As FSK gears up for its 2026 earnings call, investors should focus on revenue growth, margins, and capital allocation...
XRP sits near $1 as macro caution weighs on crypto. Analysts debate whether Ripple can spark a breakout in 2026, with...
Hims & Hers beat quarterly EPS but trimmed full-year guidance, extending a slide in its stock as regulatory headwinds...
Roadrunner, the AI-powered CPQ startup, today disclosed a $27 million funding round led by Kleiner Perkins and FOUNDE...
A notable insider transaction at REX raised questions for investors. This guide explains what investors should know, ...
U.S. equities fell after inflation data exceeded expectations and AI disruption fears grew. Tech-led losses and risin...